Palladium (Pd): Properties, coordination chemistry and applications against cancer
DOI:
https://doi.org/10.33448/rsd-v14i3.48533Keywords:
Cancer, Palladium (Pd), Coordination chemistry, Chemotherapy.Abstract
The present manuscript consists of a review study concerning palladium(II) metal complexes aiming at their possible application in the fight against cancer. Since the advent of the so-called “cisplatin”, many efforts have been made to improve the results of the reference chemotherapy treatment of this “cisplatin” complex and its analogues and successors, such as second and third generation platinum complexes, among others. The physicochemical similarity between palladium and platinum, especially with respect to coordination chemistry, makes palladium complexes good candidates to replace and, eventually, surpass the quality of the therapeutic effects of platinum complexes. Therefore, the objective of this article is to discuss, through a bibliographic review, the fundamental aspects of the coordination chemistry of palladium (Pd) and its mechanism of action in biological media aiming at its use against various types of cancer, as a possible replacement for the classical platinum (Pt) complexes used against cancer cells. Finally, future perspectives for the applications of palladium (Pd) complexes in chemotherapy as an “anticancer agent” are presented.
Downloads
References
Abas, H. H., Al-assadi, M. J. B., & AL-Luaibi, M. Y. (2023). New Ruthenium(II), Palladium(II) and Platinum(II) Complexes of Heterocyclic Organochalcogenide Ligands: Synthesis, Characterization, and Evaluation of Anticancer Activity Against Breast Cancer Cells. Indonesian Journal of Chemical Science, 12(1).
Abu-Safieh, K. Y. A., Abu-Surrah, A. S., Tabba, H. D., AlMasri, H. A., Bawadi, R. M., Boudjelal, F. M., & Tahtamouni, L. H. (2016). Novel Palladium(II) and Platinum(II) Complexes with a Fluoropiperazinyl Based Ligand Exhibiting High Ctytotoxicity and Anticancer Activity In Vitro. Journal of Chemistry, ID 7508724 (7p).
Adibi, H., Zandieh, N., & Mansouri, K. (2015). Cytotoxic effects of palladium complexes containing squaric ligands and sulfosuccnic acid on cancer cell lines. Journal of Kermanshah University of Medical Sciences, 18(11), e73996.
Caires, A. C. F. (2007). Recent Advances Involving Palladium (II) Complexes for the Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry – Anti-Cancer Agents), 7(5), 484-91.
Calvert, H., Judson, I. & van der Vijgh, W. J. (1993). Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity. Cancer Survivor, 17, 189-17.
Carneiro, T. J., Martins, A. S., Marques, M. P. M., & Gil, A. M. (2020). Metabolic Aspects of Palladium(II) Potential Anti-Cancer Drugs. Frontiers in Oncology, 10, Article 590970 (8p).
Czarnomysy, R., Radomska, D., Szewczyk, O. K., Roszczenko, P., & Bielawski, K. (2021). Platinum and Palladium Complexes as Promising Sources for Antitumor Treatmens. International Journal of Molecular Sciences, 22, 8271 (29p).
Das, M., & Livingstone, S. E. (1978). Metal chelates as anti-cancer agents. II cytotoxic action of palladium and platinum complexes of 6-mercaptopurine and thioguanine. British Journal of Cancer, 38, 325-28.
Espino, J., Fernández-Delgado, E., Estirado, S., Cruz-Martinez, F., Villa-Carballar, S., Viñuelas-Zahínos, E., Luna-Giles, F., & Pariente, J. A. (2020). Synthesis and structure of a new thiazoline-based palladium(II) complex that promotes cytotoxicity and apoptosis of human promyelocytic leukemia HL-60 cells. Nature research – Scientific Reports, 10, 16745.
Fontes, A. P. S., Almeida, S. G., & Nader, L. A. (1997). Compostos de platina em quimioterapia do câncer. Química Nova, 20(4), 398-06.
Hassan, S. S., Hosny, W. M., & Khalf-Alla, P. A. (2024). Anti-hepatic cancer, Antioxidant and Anti-inflammatory Effects of Palladium(II) Nano-Complex. Egyptian Journal of Chemistry, 67(1), 167-79.
Hussaini, S. Y., Haque, R. A., Fatima, T., Agha, M. T., Abdul Majid, A. M. S., & Razali, M. R. (2018). Journal of Coordination Chemistry, 71(16-18) (7p).
Johnstone, T. C., Park, G. Y., & Lippard, S. J. (2014). Understanding and Improving Platinum Anticancer drugs – Phenanthriplatin. Anticancer Research, 34, 471-76.
Krstic, A., Pavic, A., Avdovic, E., Markovic, Z., Stevanovic, M., & Petrovic, I. (2022). Coumarin-Palladium(II) Complex Acts as a Potent and Non-Toxic Anticancer Agent against Pancreatic Carcinoma Cells. Molecules, 27, 2115.
Kumar, A., Naaz, A., Prakasham, A. P., Gangwar, M. K., Butcher, R. J., Panda, D., & Gosh, P. (2017). Potent Anticancer Activity with High Selectivity of a Chiral Palladium N-Heterocyclic Carbene Complex. ACS Omega, 2, 4632-46.
Lazarevic, T., Rilak, A., & Bugarcic, Z. D. (2017). Platinum, Palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives. European Journal of Medicinal Chemistry, 142, 8-31.
Lee, J. D. (2003). Química Inorgânica não tão Concisa[trad. Henrique E. Toma; Koiti Araki, Reginaldo C. Rocha]. Editora Edgar Blücher Ltda., São Paulo-SP, 1a ed. (3a reimp. Da 5a ed. Inglesa).
Lisic, E. C., Grossarth, S. N., Bowman, S. B., Hill, J. L., Beck, M. W., Deweese, J. E., & Jiang, X. (2022). New Copper(II), Palladium(II) and Platinum(II) 2-Acetylpyrazine Tert-Butylthiosemicarbazone Complexes: Inhibition of Human Topoisomerase Iia and Activity against Breast Cancer Cells. Open Journal of Medicinal Chemistry, 12(1) (16p) DOI: 10.4236/omjc.2022.121001 (https://doi.org/10.4236/ojmc.2022.121001)
Maia, P. I. S., Graminha, A., Pavan, F. R., Leite, C. Q. F., Batisa, A. A., Back, D. F., Lang, E. S., Ellena, J. Lemos, S. S., Salistre-de-Araujo, H. S., & Deflon, V. M. (2010). Journal of the Brazilian Chemical Society, 21(7), 1177-86.
Marques, M. P. M. (2013). Platinum and Palladium Polyamine Complexes as Anticancer Agents: The Structural Factor. ISRN Spectroscopy, ID 287353 (29p).
Mbugua, S. N., Sibuyi, N. R. S., Njenga, L. W., Odhiambo, R. A., Wandiga, S. O., Meyer, M., Lalancette, R. A., & Onani, M. O. (2020). New Palladium(II) and Platinum(II) Complexes Based on Pyrrole Schiff Bases: Synthesis, Characterization, X-ray Structure, and Anticancer Activity. ACS Omega, 5, 14942-54.
Moreira, L. M., & Lyon, J. P. (2025). Platina (Pt): Complexos metálicos e suas aplicações contra o câncer. Research, Society and Development, 14(3), e-4514348475 (9p).
Moreira, L. M., & Lyon, J. P. (2025). Rutênio (Ru): Propriedades, compostos de coordenação e aplicações catalíticas e farmacológicas. Research, Society and Development, 14(1), e6114148046.
Moreira, L. M., Lyon, J. P., Pereira, C., Silva, R. S., & Schultz, M. S. (2024). Manganês (Mn): Propriedades redox, química de coordenação e implicações biológicas. Research, Society and Development, 13(2), (2024) e13713245186.
Moreira, L. M., Lyon, J. P., & Teixeira, A. O. (2023). A relação estrutura-atividade da Vitamina B12 e das cobalaminas e suas correlações nutricionais. Research, Society and Development, 12(11), e05121143658.
Moreira, L. M., Teixeira, A. O., & Lyon, J. P. (2024). Cobre (Cu): Reatividade, compostos de coordenação e atuação biológica. Research, Society and Development, 13(3), e5313345291.
Moreira, L. M., Teixeira, A. O., & Lyon, J. P. (2023). A flexibilidade dos anéis macrocíclicos e as diferentes conformações espaciais de macrocíclicos metalados e não-metalados. Research, Society and Development, 12(10), e28121043407.
Moreira, L. M., Teixeira, A. O., & Lyon, J. P. (2022). Métodos Fototerapêuticos de relevância clínica. Research, Society and Development, 11(5), e51411528589.
Najjar, R. (1992). Complexos metálicos com atividade anticancerígena. Química Nova, 15, 323-27.
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica [free e-book/repositório.ufsm.br]. Ed. UFSM. https://www.ufsm.br/app/uploads/sites/358/2019/02/Metodologia-da-Pesquisa-Científica_final.pdf
Rother, E. T. (2007). Revisão Sistemática X Revisão Narrativa. Acta Paulista de Enfermagem, 20(2), https://doi.org/10.1590/S0103-21002007000200001.
Sarto, L. E., Gois, E. P., Andrade, G. G., Almeida, M .S., Freitas, J. T. J., Reis Júnior, A. S., Franco, L. P., Torres, C., Almeida, E. T., & Gouvêa, C. M. C. P. (2019). Anticancer Potential of Palladium(II) Complexes with Schiff Bases Derived from 4-Aminoacetophenone against Melanoma In Vitro. Anticancer Research, 39, 6693-99.
Scattolin, T., Voloshkin, V. A., Visentin, F., & Nolan, S. P. (2021). A critical review of palladium organometallic anticancer agents. Cell Reports Physical Science, 2, 100446.
Schleser, S. W., Krytovych, O., Ziegelmeier, T., Grob, E., Kasparkova, J., Brabec, V., Weber, T., Schobert, R., & Mueller, T. (2023). Palladium and Platinum Complexes of the Animetabolite Fludarabine with Vastly Enhanced Seletivity for Tumour over Non-Malignant Cells. Molecules, 28, 5173(11p).
Sen, V. D., Terentiev, A. A., & Konovalova, N. P. (2012). Platinum Complexes with Bioactive Nitroxyl Radicals: Synthesis and Antitumor Properties. In: Nitroxides – Theory, Experiment and Applications. [Edited by Alexander I. Kokorin].
Shriver, D. F., Atkins, P. W., Overton, T. L., Rourke, J. P., Weller, M. T. & Armstrong, F. A. (2008). Química Inorgânica [Trad. Roberto B. Farias; Cristina M. P. dos Santos] 4aed. Artmed Editora S. A., Porto Alegre-RS.
Simic, D., Zaric, M., Jakovljevic, S., Pantic, K., Petrovic, D., Milic, S. J., & Canovic, P. (2022). Antitumor Activity of Palladium(II) Complexes on Du-145 Cell Line In Vitro. Sciendo, Apr2022, DOI: https://doi.org/10.2478/sjecr-2022-0003.
Tanaka, M., Kataoka, H., Yano, S., Ohi, H., Kawamoto, K., Shibahara, T., Mizoshita, T., Mori, Y., Tanida, S., Kamiya, T., & Joh, T. (2013). Anti-cancer effects of newly developed chemotherapeutic agente, glycoconjugated palladium(II) complex, against cisplatin-resistant gastric cancer cells. BMC Cancer, 13, 237 (9p).
Vojtek, M., Marques, M. P. M., Ferreira, I. M. P. L. O., Mota-Filipe, H., & Diniz, C. (2019). Anticancer activity of palladium-based complexes Against triple-negative breast cancer. Drug Discovery Today, 24, 1044-58.
Zhang, C., Xu, C., Gao, X., & Yao, Q. (2022). Platinum-based drugs for cancer therapy and anti-tumor strategies. Theranostics, 12, 2115-32.
Zhou, M., Boulos, J. C., Omer, E. A., Rudbari, H. A., Schirmeister, T., Micale, N. & Efferth, T. (2023). Two palladium (II) complexes derived from halogen-substituted Schiff bases and 2-picolylamine induce parthanatos-type cell death in sensitive and multi-drug resistant CCRF-CEM leukemia cells. European Journal of Pharmacology, 956, 175980.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Leonardo Marmo Moreira; Juliana Pereira Lyon
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
